Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Coronavirus vaccine - Sanofi pasteur

Drug Profile

Coronavirus vaccine - Sanofi pasteur

Alternative Names: COVID-19

Latest Information Update: 28 Mar 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Institute of Allergy and Infectious Diseases; sanofi pasteur
  • Developer Biomedical Advanced Research and Development Authority; Sanofi Pasteur
  • Class COVID-19 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported COVID 2019 infections
  • Discontinued Severe acute respiratory syndrome

Most Recent Events

  • 28 Mar 2024 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in USA (Parenteral)
  • 24 Feb 2020 Sanofi Pasteur reinitiates the development of coronavirus vaccine in collaboration with Biomedical Advanced Research and Development Authority
  • 18 Feb 2020 Sanofi Pasteur collaborates with Biomedical Advance Research and Development Authority (BARDA) from US Department of Health and Human Services for development of coronavirus vaccine
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top